Intrathecal baclofen for severe torsion dystonia in a child

G. Paret*, R. Tirosh, B. Ben Zeev, A. Vardi, N. Brandt, Z. Barzilay

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


The successful use of intrathecal baclofen, a structural analogue of γ-aminobutyric acid, is described in the treatment of a 9-year-old boy with intractable torsion dystonia, not responding to conservative treatment. To our knowledge, this is the first reported case of continuous intrathecal baclofen for hereditary torsion dystonia. This case suggests that a continuous intrathecal infusion of baclofen may facilitate remission of intractable torsion dystonia, and provides a basis for further investigation of the treatment of intractable childhood dystonia.

Original languageEnglish
Pages (from-to)635-637
Number of pages3
JournalActa Paediatrica, International Journal of Paediatrics
Issue number5
StatePublished - 1996
Externally publishedYes


  • Baclofen
  • Dystonia
  • Intrathecal


Dive into the research topics of 'Intrathecal baclofen for severe torsion dystonia in a child'. Together they form a unique fingerprint.

Cite this